 |
| No |
Author |
Title |
Journal |
Vol(Issue),Page |
PMID |
| 1 |
Limdi NA, Wadelius M, ~ Pirmohamed M, Shin JG, ~ Klein TE, Wagner MJ.
|
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across three racial groups.
|
Blood
|
115(18):3827-34
|
20203262 |
| 2 |
International Warfarin Pharmacogenetics Consortium.
|
Pharmacogenetic Dose Refinements Remain Significantly Influenced by Genetic Factors after INR Measurements through One Week of Warfarin Therapy
|
Blood
|
in press
|
? |
| 3 |
Kim EY, Lee SS, Jung HJ, Jung HE, Yeo CW, Shon JH, Shin JG
|
Robust CYP2D6 Genotype Assay including Copy Number Variation using Multiplex Single-Base Extension for Asian Populations
|
Clinica Chimica Acta
|
in press
|
20828547 |
| 4 |
Lee SJ, Kim WY, Choi JY, Lee SS, Shin JG.
|
Identification of CYP19A1 single nucleotide polymorphisms and their haplotype distributions in a Korean population
|
J Hum Genet.
|
55(3):189-93
|
20186154 |
| 5 |
Hwang MS, Lee SJ, Jeong HE, Lee S, Yoo MA, Shin JG
|
Genetic variations in UDP-glucurosyltransferase 2B7 gene (UGT2B7) in a Korean population
|
Drug Metab Pharmacokinet.
|
25(4):398-402
|
20814162 |
| 6 |
Lee SJ, Jang YJ, Cha EY, Kim HS, Lee SS, Shin JG
|
"A haplotype of CYP2C9 associated with warfarin sensitivity in mechanical heart valve replacement patients
|
Br J Clin Pharmacol
|
70(2):213-21.
|
20653674 |
| 7 |
Bae SK, Park SJ, Shim EJ, Mun JH, Kim EY, Shin JG, Shon JH.
|
Increased Oral Bioavailability of Itraconazole and Its Active Metabolite, 7-Hydroxyitraconazole, When Coadministered With a Vitamin C Beverage in Healthy Participants.
|
J Clin Pharmacol
|
in press
|
20400647 |
| 8 |
Kim H, Bae SK, Park SJ, Shim EJ, Kim HS, Shon JH, Liu KH, Shin JG
|
Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects.
|
Br J Clin Pharmacol
|
70(1), 126?131
|
20642555 |
[1][2]
|
 |
|
